ArticleJournal for immunotherapy of cancer2026
Targeting AKR1B1 reprograms tumor-associated macrophages to enhance antitumor immunity.
Yuqing Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it